Global Quinolones Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
USD
48.80 Billion
USD
69.40 Billion
2022
2030
 Período de previsão |
2023 –2030 |
 Tamanho do mercado (ano base ) | USD 48.80 Billion |
 Tamanho do mercado ( Ano de previsão) | USD 69.40 Billion |
 CAGR |
% |
| Principais participantes do mercado |
>Global Quinolones Market, By Disease Type (Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections and Others), Pathogen Type (Gram-Positive Pathogen, Gram-Negative Pathogen), Drugs (Lomefloxacin, Gatifloxacin, Norfloxacin, Moxifloxacin, Ciprofloxacin and Others), Route of Administration (Oral, Injectable, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Quinolones Market Analysis and Size
The demand for quinolones is increasing on account of US$ 56.8 billion by 2026. Growing demand for quinolones is also estimated to leadto the growth of the quinolones market share. The rise in incidence of infectious diseases globally acts as one of the primary factors enhancing the growth of quinolones market. Numerous quinolones are currently available for the treatment of animals globally which includes poultry and fish.
Data Bridge Market Research analyses a growth rate in the quinolones market in the forecast period 2023-2030. The expected CAGR of the quinolones market tends to be around 4.5% in the mentioned forecast period. The market value is USD 48.8 billion in 2022, and it would grow up to USD 69.40 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Quinolones Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 - 2020) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Disease Type (Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections and Others), Pathogen Type (Gram-Positive Pathogen, Gram-Negative Pathogen), Drugs (Lomefloxacin, Gatifloxacin, Norfloxacin, Moxifloxacin, Ciprofloxacin and Others), Route of Administration (Oral, Injectable, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
GSK plc (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Abbvie, Inc (U.S.), Pfizer Inc (U.S.), Viatris Inc. (U.S.), Lupin (India), Hikma Pharmaceuticals PLC (U.K.), Zydus Group (India), Bausch Health Companies Inc. (Canada), KYORIN Holdings, Inc (Japan), MerLion Pharmaceuticals GmbH (Germany), WOCKHARDT (India), Johnson & Johnson Private Limited (U.S.), Teva Pharmaceutical Industries Ltd.(Israel) and Sanofi (France) |
|
Market Opportunities |
|
Market Definition
A quinolone antibiotic is a broad-spectrum bactericide which has a bicyclic core structure having the chemical 4-quinolone. Quinolones are used to treat several bacterial infections in veterinary and human medicine and animal husbandry. They are classified into five distinct classes, in which one is antibiotics. Quinolones are highly effective against stomach, skin, lungs, sinuses, and urinary tract bacterial infections.
Quinolones Market Dynamics
Drivers
- Increased Awareness About Health Issues
Growing health awareness and increasing disposable income have encouraged people to drift towards healthy products, which will benefit them from the adverse health effects. Rising incidence of multidrug-resistant bacteria, raises public health concerns and also creates opportunities for medication producers. Furthermore, the European Medicines Agency's pharmacovigilance risk assessment committee has advised restricting many antibiotics by mouth, inhalation, or injection because of their long-lasting adverse effects. Thus, this expands the market growth.
Opportunities
- Growing Launch of Products
There has been launch of several products that are helpful for the market growth. For instance, in January 2018, Melinta Therapeutics, Inc. launched Baxdela. Baxdela is an oral fluoroquinolone used to treat adult patients with susceptible bacterial acute bacterial skin and skin structure infections (ABSSSI). Baxdela's introduction offers a new therapy alternative and expands the company's infection therapies space. Furthermore, KYORIN Holdings, Inc. announced that the Japanese Ministry of Health, Labor, and Welfare approved Lasvic (lascufloxacin hydrochloride), in September 2019, indicated as a first-line monotherapy for treating community-acquired respiratory and ENT infections. Lasvic's approval is a major milestone in the company's efforts to protect the increasing danger of antimicrobial resistance and provide patients with suitable treatment alternatives.
Restraints/Challenges
- Adverse Effects of Quinolones
Several side-effects are associated with the use of quinolones, because of which some of the drugs such as Tequin manufactured by Bristol-Myers Squibb have been withdrawn from the market in a very short span after their launch in 2006. As per the United States Food & Drug Administration, Tequin was discontinued because of the adverse reactions in 2.7% of more than 5,000 treated patients. Thus, the adverse effects are restraining the market growth.
This quinolones market market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the quinolones market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth
Global Quinolones Market Scope
The quinolones market is segmented on the basis of disease type, pathogen type, drugs, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Disease Type
- Urinary Tract Infection
- Intra-Abdominal Infections
- Blood Stream Infections
- Clostridium Difficile Infections
- Others
Pathogen Type
- Gram-Positive Pathogen
- Gram-Negative Pathogen
Drugs
- Lomefloxacin
- Gatifloxacin
- Norfloxacin
- Moxifloxacin
- Ciprofloxacin
- Others
Route of Administration
- Oral
- Injectable
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Quinolones Market Regional Analysis/Insights
The quinolones market is analyzed and market size insights and trends are provided by disease type, pathogen type, drugs, route of administration, end users and distribution channel as referenced above.
The major countries covered in the quinolones market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing the highest growth for the quinolones market throughout the forecasted period because of the increasing level of disposable income.
North America dominates the market due to the growing number of R&D activities and increasing healthcare expenditure that will boost the market's growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Quinolones Market Share Analysis
The quinolones market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to quinolones market.
Key players operating in the quinolones market include:
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Abbvie, Inc (U.S.)
- Merck & Co., Inc. (U.S.)
- Pfizer Inc (U.S.)
- Viatris Inc. (U.S.)
- Lupin (India)
- Hikma Pharmaceuticals PLC (U.K.)
- Zydus Group (India)
- Bausch Health Companies Inc. (Canada)
- KYORIN Holdings, Inc (Japan)
- MerLion Pharmaceuticals GmbH (Germany)
- WOCKHARDT (India)
- Johnson & Johnson Private Limited (U.S.)
- Teva Pharmaceutical Industries Ltd.( Israel)
- Sanofi (France)
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
